+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Recent Innovations in Biopharmaceutical and Biomarker Technologies

  • ID: 4775837
  • Report
  • June 2019
  • Region: Global
  • 15 Pages
  • Frost & Sullivan
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abacus Diagnostica Oy
  • Akouos
  • BluSense Diagnostic ApS
  • Eyestem
  • Lung Therapeutics
  • Quell Therapeutics
  • MORE

This edition of the  Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises 26 recent technology innovations across the biopharmaceutical and biomarker platforms for research and clinical applications across the global healthcare industry. The research captures key innovation aspects such as technology readiness levels, market potential, funding, disruptive potential, mega trend impact, and regional adoption scenarios to evaluate the innovation index for each technology profile. A summary of the innovation index has also been provided in a visual radar format.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abacus Diagnostica Oy
  • Akouos
  • BluSense Diagnostic ApS
  • Eyestem
  • Lung Therapeutics
  • Quell Therapeutics
  • MORE

1. Innovators in US & Canada

  • Allogene Therapeutics
  • Gossamer Bio
  • Magnolia Neurosciences Corporation
  • Akouos
  • Akero Therapeutics
  • Protochips
  • HOOKIPA Pharma Inc.
  • Aviana Molecular Technologies LLC
  • Cue Health Inc.
  • Co-Diagnostics Inc.
  • Ontera Inc.
  • SeLux Diagnostics Inc.
  • SpringWorks Therapeutics
  • Lung Therapeutics

2. Innovators in Europe

  • Abacus Diagnostica Oy
  • Abionic SA
  • BluSense Diagnostic ApS
  • SAW Diagnostics Limited
  • Aelix Therapeutics
  • GammaDelta Therapeutics
  • Quell Therapeutics

3. Innovators in India

  • Cure.Fit
  • Mitra Biotech
  • ATGC Biotech
  • Eyestem
  • Aura Biotechnologies

4. Innovation Radar

5. Appendix

  • Summary of the Scoring Methodology
  • Key Contacts
Note: Product cover images may vary from those shown
3 of 3
  • ATGC Biotech
  • Abacus Diagnostica Oy
  • Abionic SA
  • Aelix Therapeutics
  • Akero Therapeutics
  • Akouos
  • Allogene Therapeutics
  • Aura Biotechnologies
  • Aviana Molecular Technologies LLC
  • BluSense Diagnostic ApS
  • Co-Diagnostics Inc.
  • Cue Health Inc.
  • Cure.Fit
  • Eyestem
  • GammaDelta Therapeutics
  • Gossamer Bio
  • HOOKIPA Pharma Inc.
  • Lung Therapeutics
  • Magnolia Neurosciences Corporation
  • Mitra Biotech
  • Ontera Inc.
  • Protochips
  • Quell Therapeutics
  • SAW Diagnostics Limited
  • SeLux Diagnostics Inc.
  • SpringWorks Therapeutics
Note: Product cover images may vary from those shown
Adroll
adroll